Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

9480	Companies
185562	Keywords
117961	Articles
99395	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 01/13/2025 at 07:05, 10 months 23 days ago

Teva s'associe à Formycon pour le biosimilaire FYB203 en Europe et en Israël

Formycon Biosimilaires Teva FYB203 L'Europe Et Israël
PRESS RELEASE

published on 01/13/2025 at 07:00, 10 months 23 days ago

Teva becomes strategic commercialization partner for Formycon’s biosimilar candidate FYB203 (Eylea®/ aflibercept) in major parts of Europe and Israel
Teva partners with Formycon for commercialization of biosimilar FYB203 (Eylea®) in Europe and Israel, aiming to expand access to innovative medicines

Biosimilar Formycon Teva FYB203 Eylea
BRIEF

published on 01/09/2025 at 15:35, 10 months 27 days ago

Formycon Joins TecDAX Index

Stock Market Biosimilars Deutsche Börse TecDax Formycon
BRIEF

published on 01/09/2025 at 15:35, 10 months 27 days ago

Formycon rejoint l'indice TecDAX

Bourse TecDax Formycon Biosimilaires Bourse Allemande
PRESS RELEASE

published on 01/09/2025 at 15:30, 10 months 27 days ago

Formycon included in TecDAX Index of Deutsche Börse
Formycon AG to be included in TecDAX Index of Deutsche Börse, enhancing visibility and market position. Company specializes in biosimilars for various disease areas

Formycon AG Biosimilars Deutsche Börse TecDAX Index Technology Stocks
BRIEF

published on 01/08/2025 at 14:35, 10 months 28 days ago

Health Canada Approves Formycon's Biosimilar FYB202/Otulfi®

Healthcare Costs Biosimilar Formycon Ustekinumab Canada Approval
BRIEF

published on 01/08/2025 at 14:35, 10 months 28 days ago

Santé Canada approuve le médicament biosimilaire FYB202/Otulfi® de Formycon

Formycon Ustekinumab Coûts Des Soins De Santé Biosimilaire Approbation Du Canada
PRESS RELEASE

published on 01/08/2025 at 14:30, 10 months 28 days ago

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Formycon and Fresenius Kabi Canada obtain Health Canada's approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®

Health Canada Approval Biosimilar Formycon Stelara Fresenius Kabi Canada
BRIEF

published on 12/11/2024 at 16:31, 11 months 25 days ago

Formycon AG Maintains Strong Growth Prospects Amidst Challenging Market Conditions

FDA Approval Revenue Decline Formycon AG Biosimilars Stelara Launch
BRIEF

published on 12/11/2024 at 16:31, 11 months 25 days ago

Formycon AG maintient de solides perspectives de croissance dans un contexte de marché difficile

Formycon AG Baisse Des Revenus Approbation De La FDA Biosimilaires Lancement De Stelara

Accesswire

Published on 12/05/2025 at 22:50, 36 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 1 hour 41 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 56 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 6 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 2 hours 26 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 1 hour 11 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 14 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 28 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 5 hours 11 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 8 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE